Aarti Pharmalabs submits Business Responsibility and Sustainability Report for FY26
Aarti Pharmalabs Limited has submitted its Business Responsibility and Sustainability Report for FY 2025-26. The report details the company's operations, market reach, and sustainability initiatives, in compliance with SEBI regulations. It is available on the company's website.
This is a routine compliance filing of a sustainability report, which is standard practice for listed companies and does not introduce new material information that would directly affect the company's operations or stock price.
The announcement is a routine regulatory filing and does not contain any new financial performance data or strategic updates that would significantly impact the company's valuation or outlook.
Aarti Pharmalabs Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26. This submission is in continuation of their earlier intimation regarding the Annual Report and Notice of the 7th Annual General Meeting, and is in compliance with Regulation 34(2)(f) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The BRSR for FY 2025-26 is also made available on the company's website at https://www.aartipharmalabs.com/business-responsibilty-report.
The report details various aspects of the company's operations, including its corporate identity, business activities which are 100% focused on manufacturing Pharmaceuticals and Nutraceuticals, and its market reach, serving 25 states nationally and 51 countries internationally, with exports accounting for approximately 55.93% of its total turnover.
It also provides comprehensive data on employees and workers, with a total of 2033 employees and 2185 workers as of March 31, 2026. The report highlights the company's commitment to sustainability, outlining material responsible business conduct issues, its approach to managing environmental and social risks, and its CSR activities. The company has also detailed its policies and governance structures related to sustainability, including its adherence to various national and international codes and certifications.
A plain-language summary of a public exchange filing by Aarti Pharmalabs Limited. Read the original for the full detail.